A pregnant dilemma: Primary hyperparathyroidism due to parathyromatosis in pregnancy

Endocrine Practice

Volumn 20, Issue 2, 2014, Pages

  Edling, Kari L ^a   Korenman, Stanley G ^a   Janzen, Carla ^a   Sohsman, Marie Y ^a   Apple, Sophia K ^a   Bhuta, Sunita ^a   Yeh, Michael W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84894134518     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP13105.CR     Document Type: Article

References (16)

1. Hage MP, Salti I, El-Hajj Fuleihan G. Parathyromatosis: a rare yet problematic etiology of recurrent and persistent hyperparathyroidism. Metabolism. 2012;61:762-775.
2. Kovacs CS. Calcium and bone metabolism disorders during pregnancy and lactation. Endocrinol Metab Clin North Am. 2011;40:795-826.
3. Malekar-Raikar S, Sinnott BP. Primary hyperparathyroidism in pregnancy-a rare cause of life-threatening hypercalcemia: case report and literature review. Case Rep Endocrinol. 2011;2011:520516.
4. Sato K. Hypercalcemia during pregnancy, puerperium, and lactation: review and a case report of hypercalcemic crisis after delivery due to excessive production of PTH-related protein (PTHrP) without malignancy (humoral hypercalcemia of pregnancy). Endocr J. 2008;55:959-966.
5. Eller-Vainicher C, Ossola MW, Beck-Peccoz P, Chiodini I. PTHrP-associated hypercalcemia of pregnancy resolved after delivery: a case report. Eur J Endocrinol. 2012;166:753-756.
6. Yeh MW, Ituarte PH, Zhou HC, et al. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab. 2013;98:1122-1129.
7. Haglund F, Ma R, Huss M, et al. Evidence of a functional estrogen receptor in parathyroid adenomas. J Clin Endocrinol Metab. 2012;97:4631-4639.
8. Tachibana S, Yokoi T, Sato S, Yanase T, Yamashita H. Surgically proven normocalcemic primary hyperparathyroidism: speculation of the possible role of estrogen in the etiology of this disease in premenopausal women. Intern Med. 2013;52:781-785.
9. McMullen TP, Learoyd DL, Williams DC, Sywak MS, Sidhu SB, Delbridge LW. Hyperparathyroidism in pregnancy: options for localization and surgical therapy. World J Surg. 2010;34:1811-1816.
10. Norman J, Politz D, Politz L. Hyperparathyroidism during pregnancy and the effect of rising calcium on pregnancy loss: a call for earlier intervention. Clin Endocrinol (Oxf). 2009;71:104-109.
11. Steddon SJ, Cunningham J. Calcimimetics and calcilytics-fooling the calcium receptor. Lancet. 2005;365:2237-2239.
12. Nemeth EF, Steffey ME, Hammerland LG, et al. Calcimimetics with potent and selective activity on the parathyroid calcium receptor. Proc Natl Acad Sci U S A. 1998;95:4040-4045.
13. Peacock M, Bilezikian JP, Bolognese MA, et al. Cinacalcet HCl reduces hypercalcemia in primary hyperparathyroidism across a wide spectrum of disease severity. J Clin Endocrinol Metab. 2011;96:E9-18.
14. Unbehaun R, Lauerwald W. Successful use of cinacalcet HCl in a patient with end-stage renal failure and refractory secondary hyperparathyroidism due to parathyromatosis. Clin Nephrol. 2007;67:188-192.
15. Daphnis E, Stylianou K, Katsipi I, et al. Parathyromatosis and the challenge of treatment. Am J Kidney Dis. 2006;48:502-505.
16. Horjus C, Groot I, Telting D, et al. Cinacalcet for hyperparathyroidism in pregnancy and puerperium. J Pediatr Endocrinol Metab. 2009;22:741-749.